Insider · CIK 0001773532
Georgia Keresty
Files at NTLA (Intellia Therapeutics, Inc.), SLDB (Solid Biosciences Inc.). First filing -, latest -.
In brief
Georgia Keresty files SEC Form 4 as director at NTLA (Intellia Therapeutics, Inc.), and also at SLDB (Solid Biosciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Georgia Keresty has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | SLDB Solid Biosciences Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +77,500 | $0.00 | $0 | 77,500 | Jun 11, 2026 |
| Jun 9, 2026 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +9,200 | $0.00 | $0 | 41,083 | Jun 10, 2026 |
| Jun 9, 2026 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +13,300 | $0.00 | $0 | 13,300 | Jun 10, 2026 |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +77,500 | $0.00 | $0 | 77,500 | Jun 18, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 31,883 | Jun 18, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,450 | $0.00 | $0 | 11,450 | Jun 18, 2025 |
Questions about Georgia Keresty
Answered from the filings on this page, as of the latest one.
Is Georgia Keresty buying or selling?
Georgia Keresty has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Georgia Keresty's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Georgia Keresty has 0.
Where does Georgia Keresty file Form 4?
Georgia Keresty has filed Form 4 at NTLA (Intellia Therapeutics, Inc.); SLDB (Solid Biosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.